文献速递间质性肺疾病肺结节与肺癌

成人间质性肺异常的患病率、危险因素与结局:系统综述与荟萃分析

Prevalence, Risk Factors, and Outcomes of Adult Interstitial Lung Abnormalities: A Systematic Review and Meta-Analysis.
PubMed 文献 · Am J Respir Crit Care Med · 2023-01-01

该系统综述与荟萃分析纳入22项研究共88,325名参与者,评估胸部CT偶然发现的间质性肺异常(ILA)的患病率。ILA合并患病率在肺癌筛查人群为7%(95%CI 0.01-0.13),一般人群为7%(95%CI 0.04-0.10),家族性高危队列为26%(95%CI 0.20-0.32)。ILA与死亡风险增加相关(OR 3.56,95%CI 2.19-5.81),高龄、男性和较低FVC%与ILA风险相关。

要点

  • 肺癌筛查和一般人群中ILA患病率约7%,家族性高危队列达26%。
  • ILA与死亡风险增加约3.5倍相关(OR 3.56,95%CI 2.19-5.81)。
  • 高龄、男性和较低FVC%与更高ILA风险相关。

核心结论

  • 因非间质性肺疾病指征接受影像检查的人群中ILA患病率较高,需标准化报告和随访。

研究设计与样本

  • 系统综述与荟萃分析,检索Embase和Medline,最终纳入22项研究共88,325名参与者。
  • 研究方案注册于PROSPERO(CRD42022373203),遵循MOOSE推荐。
  • 采用随机效应模型合并特定亚组患病率估计和ILA相关死亡风险。

主要发现

  • 肺癌筛查人群ILA合并患病率为7%(95%CI 0.01-0.13)。
  • 一般人群ILA合并患病率为7%(95%CI 0.04-0.10)。
  • 家族性队列ILA合并患病率为26%(95%CI 0.20-0.32)。
  • ILA患者合并死亡风险增高(OR 3.56,95%CI 2.19-5.81)。
  • 高龄、男性和较低FVC%与ILA风险增加相关。

关键数值与推荐

  • 肺癌筛查人群ILA患病率7%(95%CI 0.01-0.13)。
  • 一般人群ILA患病率7%(95%CI 0.04-0.10)。
  • 家族性队列ILA患病率26%(95%CI 0.20-0.32)。
  • ILA相关死亡风险OR 3.56(95%CI 2.19-5.81)。

临床怎么用

  • 对肺癌筛查、一般人群及家族性高危人群的胸部CT应关注ILA的标准化报告。
  • 识别高龄、男性和较低FVC%等ILA高风险特征,以便随访。
  • 需定义进展为ILED最高风险人群以指导随访策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Incidental parenchymal abnormalities detected on chest computed tomography scans are termed interstitial lung abnormalities (ILAs). ILAs may represent early interstitial lung disease (ILD) and are associated with an increased risk of progressive fibrosis and mortality. The prevalence of ILAs is unknown, with heterogeneity across study populations. Objectives: Estimate the pooled prevalence of ILAs in lung cancer screening, general population-based, and at-risk familial cohorts using meta-analysis; identify variables associated with ILA risk; and characterize ILA-associated mortality. Methods: The study protocol was registered on PROSPERO (CRD42022373203), and Meta-analyses of Observational Studies in Epidemiology recommendations were followed. Relevant studies were searched on Embase and Medline. Study titles were screened and abstracts reviewed for full-text eligibility. Random effect models were used to pool prevalence estimates for specified subgroups and ILA-associated mortality risk. Risk of ILAs was estimated based on age, sex, and FVC. Quality assessment was conducted using an adapted Assessment Tool for Prevalence Studies. Measurements and Main Results: The search identified 9,536 studies, with 22 included, comprising 88,325 participants. The pooled ILA prevalence was 7% (95% confidence interval [CI], 0.01-0.13) in lung cancer screening, 7% (95% CI, 0.04-0.10) in general population, and 26% (95% CI, 0.20-0.32) in familial cohorts. Pooled mortality risk was increased in those with ILAs (odds ratio, 3.56; 95% CI, 2.19-5.81). Older age, male sex, and lower FVC% were associated with greater odds of ILA. Conclusions: Populations undergoing imaging for non-ILD indications demonstrate high ILA prevalence. Standardized reporting and follow-up of ILAs is needed, including defining those at greatest risk of progression to ILD.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Grant-Orser A, Min B, Elmrayed S, et al. Prevalence, Risk Factors, and Outcomes of Adult Interstitial Lung Abnormalities: A Systematic Review and Meta-Analysis. Am J Respir Crit Care Med. 2023. PMID: 37534937. doi:10.1164/rccm.202302-0271OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。